Company intelligence / Profile preview

Stockholm Health Economics

Stockholm, Sweden

Ownership: Private
Development stage: Other

Overview

Stockholm Health Economics (SHE) is a premier consultancy specializing in health economics, outcomes research (HEOR), and market access services. The firm provides pharmaceutical, biotech, and medical device companies with evidence-based analysis, including economic modeling, systematic reviews, and value dossier development. Founded in 1998 in Sweden, SHE is recognized for its academic excellence and deep expertise in the Nordic and European healthcare markets. The company assists clients in demonstrating the clinical and economic value of new technologies to payers and health authorities. In 2013, SHE was acquired by Mapi Group, which was subsequently acquired by ICON plc in 2017. Today, its expertise is fully integrated into ICON's global market access and HEOR division.

Industry: Consulting

Beyond the preview

Go deeper on Stockholm Health Economics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stockholm Health Economics.

Explore the full profile